Home/Macular Degeneration
Condition Deep-Dive

Age-Related Macular Degeneration

A leading cause of vision loss in older adults, and one of the few conditions where a supplement formula has moderate-certainty evidence of slowing progression1. That evidence is also among the most commonly misapplied. The AREDS formula slows intermediate AMD from turning into late AMD, including in the second eye when one eye already has late AMD, and it does not prevent AMD in people who do not have it.

Eye & Vision Evidence-Based

Last updated:

🚨 Straight lines that suddenly look bent or wavy, a new gray or blank patch in the center of your vision, or a rapid change over days, all need an eye assessment the same day rather than an appointment in a few weeks2. That pattern can mean wet AMD, and the injection treatment for it works best when it is started before scarring forms. Vision already lost to a delay does not usually come back. Nothing on this page is a reason to wait.
Definition

What Is Macular Degeneration?

Age-related macular degeneration (AMD) is damage to the macula, the small central part of the retina responsible for reading, faces and fine detail. It takes two forms. Dry AMD is gradual and far more common; it has no drug treatment except eye injections that can slow its late stage. Wet AMD is caused by abnormal blood vessels leaking under the retina; it moves much faster and does have treatment.

Peripheral vision is usually spared, so AMD does not typically cause total blindness. What it takes is the center: the part used for reading a label, recognizing a face across a room and driving. That is why it is the leading cause of severe central vision loss in older adults across the US and Europe.

Early AMD shows as drusen (small yellow deposits under the retina) and is often found on a routine eye examination before anything is noticed. The stage matters more than almost anything else on this page, because it decides whether the supplement evidence applies to you at all.

💡 Key Insight: This is a condition where the same supplement is well evidenced for one group and pointless for another. A Cochrane review found antioxidant supplements probably slow progression in people who already have AMD1. A separate Cochrane review by the same team found they do not prevent it in people who do not3. Which group you are in is the whole question.
A cross-section of the eye with yellow drusen around a darkened macula and a small leaking vessel, beside two grids, one with straight lines and one bent around a gray blank patch, and panels on urgent signs and who the formula is for

🚬 Smoking is the largest modifiable risk

A systematic review and meta-analysis of clinical risk factors found current smoking among the strongest and most consistent modifiable associations with AMD4. Stopping matters more here than any capsule does.

👁️ The formula is for a specific stage

The original trial limited its recommendation to people with extensive intermediate drusen, at least one large druse, non-central geographic atrophy or advanced AMD in one eye5. Not to everyone over 50.

⚠️ Beta-carotene was removed for a reason

Ten-year follow-up of AREDS2 reported that beta-carotene use nearly doubled the risk of lung cancer6. The current formula uses lutein and zeaxanthin instead.

By the Numbers

Macular Degeneration by the Numbers

11 million
people in the US have AMD, a leading cause of vision loss in older adults7
78 fewer
cases of progression to late AMD per 1,000 people with intermediate AMD taking the AREDS formula, against about 4 fewer per 1,000 with early AMD (moderate-certainty evidence)1
76,756
people in the prevention trials, where vitamin E and beta-carotene supplements did not prevent or delay AMD in people who did not have it3
Nearly 2ร—
the lung cancer risk with beta-carotene at 10 years of AREDS2 follow-up, confirming why the current formula uses lutein and zeaxanthin instead6
41%
lower risk of advanced AMD with high adherence to a Mediterranean diet, pooled from two European cohorts of 4,996 people; an association, not proof8
1 working day
the usual time to refer suspected wet AMD to a specialist after a same-day eye assessment, with treatment within 14 days of referral2
Signs & Symptoms

Symptoms of Macular Degeneration

It usually starts silently, because one eye compensates for the other until it cannot.

SymptomWhat happens
Straight lines appearing bent or wavyDoor frames, tiles or lines of text bowing. Worth knowing: Report this urgently. It is the classic sign of wet AMD, and treatment is time-critical.
A new gray, dark or blank patch in central visionA smudge that does not move when you look away. Worth knowing: Report this urgently. Sudden onset needs same-day eye care2.
Blurred central visionFaces harder to recognize, text harder to read. Worth knowing: Gradual blurring is more typical of dry AMD, and still needs assessing.
Needing much more light to readLamps moved closer, print held differently. Worth knowing: Common, and easy to attribute to aging, which is why diagnosis is late.
Slow adjustment coming indoorsTaking longer than it used to. Worth knowing: An early functional change people rarely mention to anyone.
Colors looking washed outLess vivid than remembered. Worth knowing: Usually gradual, and usually noticed in hindsight.
Nothing at allDrusen found on a routine eye test. Worth knowing: The most common presentation of early AMD. This is the argument for regular eye examinations.
Seeing shapes or patterns that are not thereCharles Bonnet syndrome, in significant vision loss. Worth knowing: Distressing, well recognized and not a sign of mental illness. Worth raising, because being told what it is helps a great deal.
⚠️ Check one eye at a time. AMD often starts in one eye, and the other covers for it well enough that people notice nothing for a long time. Covering each eye in turn, looking at the same object, once a week finds changes far earlier than waiting until both eyes are affected. If your clinic has given you an Amsler grid, use it as instructed. Any new distortion or new patch is a reason to be seen, not a reason to watch it for two weeks.
Causes

Causes of Macular Degeneration

The exact cause of AMD is unknown; age, family history and smoking carry the most consistent risk, and blood pressure, weight and diet add to it9.

CauseHow It Contributes to Macular DegenerationWhat Helps
AgeRisk rises with age, and people 55 and older are more likely to have AMD7Nothing changes age; regular dilated eye examinations find early AMD, which has no symptoms, as the diagnosis section describes
Family history and genesA family history of AMD is one of the strongest and most consistent risk factors4; risk is also higher in white people7A reason for regular eye examinations and for knowing your stage, since the stage decides whether the formula applies
SmokingCurrent smoking is among the strongest and most consistent associations with late AMD4Stopping smoking at any age and any stage. Smokers and former smokers should also avoid any formula containing beta-carotene, which nearly doubled lung cancer risk6
Blood pressure, heart disease and weightHigh blood pressure, cardiovascular disease and a higher body mass index are moderately and consistently associated with late AMD4, and NICE lists a BMI of 30 or more10Managing blood pressure, cardiovascular risk and weight, as the treatment section notes
Diet and inactivityLack of exercise, diets high in fat and diets low in omega-⁠3 and omega-⁠6 fats, vitamins, carotenoids and minerals make AMD more likely10; a Mediterranean pattern went with a lower risk of advanced AMD8The Mediterranean pattern, leafy greens and fatty fish in the diet section, and regular activity; for prevention this is a food pattern, since supplements did not prevent AMD3
Diagnosis

How Macular Degeneration Is Diagnosed

The examination decides your stage, and the stage decides whether any of the supplement evidence is about you.

TestWhat it shows
Dilated eye examinationDrusen, pigment changes and atrophy. This is what stages the disease5. Worth knowing: Nothing else on this list replaces it, and it is the step most often skipped.
Optical coherence tomographyA cross-section of the retina, showing the fluid that indicates wet AMD. Worth knowing: Availability varies, and a single scan is a snapshot rather than a trend.
Amsler grid, if your clinic provides oneDistortion you can detect at home between appointments. Worth knowing: Insensitive on its own and easy to do wrongly. It supplements examination rather than replacing it.
Visual acuityHow much central function remains. Worth knowing: Can look reassuring while distortion is already present.
Fluorescein angiography where indicatedLeaking abnormal vessels in suspected wet AMD. Worth knowing: Used selectively, when the treatment decision needs it.
Smoking statusThe largest modifiable risk factor4, and a contraindication to older formulas containing beta-carotene. Worth knowing: Rarely revisited once recorded, though it changes what is safe to take.
Blood pressure and cardiovascular riskShares risk factors with AMD, and worth managing regardless. Worth knowing: See high blood pressure.
What you already takeWhether you are on a formula suited to your stage, or none, or the wrong one. Worth knowing: Almost never asked, and it is where most of the avoidable error on this page sits.
💡 Ask your ophthalmologist or optometrist one specific question: what stage is my AMD? The answer decides everything that follows. Early AMD, intermediate AMD, advanced AMD in one eye and no AMD at all lead to four genuinely different answers about supplements, and a product label cannot tell you which one you are.
Treatment Comparison

Conventional and Holistic Treatment for Macular Degeneration

🌿 HOLISTIC
💊 CONVENTIONAL
🌿

Holistic / Functional Approach

Stopping smoking, a Mediterranean pattern and the right formula for your actual stage

Best-Evidenced Change
Stopping smoking: smoking was the strongest modifiable association found in a systematic review of clinical risk factors4
Where Supplements Work
Slowing progression in people who already have intermediate AMD, or advanced AMD in one eye1
Timeline
Measured in years. The trials ran five years and the follow-up ten, which tells you the honest scale
Limitation, stated plainly
Nothing here restores vision already lost, and no supplement prevents AMD in someone who does not have it3

Full Holistic Approach Includes

  • Stopping smoking, with proper support, at any age and any stage.
  • A Mediterranean dietary pattern, associated with lower incidence of advanced AMD across pooled European cohorts8.
  • Leafy greens, eggs and colored vegetables, the food sources of lutein and zeaxanthin, which is where the pigment in the macula comes from.
  • Fatty fish for the wider cardiovascular reasons, while being clear that omega-⁠3 capsules did not slow AMD progression in AREDS2 11.
  • The correct formula, only if your stage matches the trial population, agreed on with your eye clinician.
  • Sunglasses in bright light, sensible and low-cost, though the evidence is weaker than it is usually presented.
  • Managing blood pressure and cardiovascular risk, which share ground with AMD.
  • Regular dilated eye examinations, since early AMD is usually silent.
🌿 Worth knowing: the supplement evidence here is real, of moderate certainty, and it applies to one specific group1. Presenting it as an eye vitamin for everyone over 50 is the most common way this evidence gets misused, and it is why this page keeps returning to your stage.
Supplement Protocol

Evidence-Based Supplements for Macular Degeneration

A supplement recommendation backed by moderate-certainty evidence, for one clearly defined group of people1.

🚨 No supplement treats wet AMD, and none replaces the injections. Delaying assessment or treatment because a formula seems to be helping is the most dangerous thing associated with this topic, since the vision lost while waiting does not usually return. If you smoke or used to smoke, do not take any formula containing beta-carotene, and check the label rather than assuming the product was reformulated6. Tell your eye clinician everything you take.
SupplementWhat it is forTypical rangeTimingNotes & cautions
The AREDS2 formulation Slowing progression if you already have intermediate AMD, or advanced AMD in one eye. This is where the evidence sits111. Sold as a single product at the composition used in the trial. Confirm with your eye clinician that your stage matches before starting With food, usually split across the day as the product directs The zinc content is above the general population upper intake level, which is why this belongs to a supervised decision for people who meet the trial criteria rather than to general use. It includes copper for the reason in the row below. Check the label says lutein and zeaxanthin, not beta-carotene, which nearly doubled lung cancer risk in the trial follow-up6. The formula also contains high-dose vitamin E; if you take a blood thinner, tell the clinician who manages it before starting.
Copper, as part of the formula Preventing the copper deficiency that sustained high-dose zinc can cause, which is why the trial formula contains it. Included in the formulation. Not a separate purchase With the formula Do not take the zinc without the copper. Copper deficiency from sustained high-dose zinc can cause anemia and neurological problems, and it is the reason the trial formula was built this way.
Lutein and zeaxanthin The replacement for beta-carotene in the current formula. Alone against placebo the evidence was weaker, and as a substitute within the formula it performed at least as well16. Best taken as part of the formulation rather than separately, unless your clinician advises otherwise With a fat-containing meal The food sources are leafy greens and eggs, and eating them is worthwhile at any stage, including no AMD at all.
Omega-⁠3 capsules Not for slowing AMD. Adding them to the formula did not reduce progression in AREDS2 11, and ten-year follow-up did not change that6. Listed here to answer the question, not to recommend them for this purpose Not applicable They may still be appropriate for other reasons agreed on with your clinician. Buying them specifically for your eyes is buying the wrong thing. In heart trials, fish oil supplements raised the risk of atrial fibrillation, an irregular heartbeat, more so above 1 g a day15, so check any fish oil supplement with your clinician first.
🚨 What to avoid, specifically. Any formula containing beta-carotene if you smoke or have ever smoked, since ten-year follow-up of AREDS2 reported it nearly doubled lung cancer risk6 and two earlier trials found the same direction of harm1213; see lung cancer. High-dose zinc taken without copper. Products marketed to undo macular degeneration or bring back lost vision, which no supplement has been shown to do. Buying an eye formula as prevention when you have no AMD, since a Cochrane review found antioxidant supplements do not prevent or delay its onset3. And any supplement used as a reason to postpone an urgent eye assessment.
💡 Where the real leverage is. Stopping smoking, getting your stage established by dilated examination, being seen urgently for new distortion, eating the pattern rather than buying the pill, and taking the correct formula only if your stage matches the trial. That is where the evidence points.
What to Expect

What to Expect Over Time

What happens next depends on the type and stage of AMD.

Treatment and supportive care, together
First Weeks

Staging comes first, by dilated examination and a scan of the retina7. Suspected wet AMD is referred urgently, normally within 1 working day, and injections start within 14 days of referral2. Stopping smoking starts now.

Months 1 to 3

Wet AMD: injections continue, with scans of both eyes to monitor them10. Intermediate AMD, or late AMD in one eye: the AREDS2 formula, agreed on with your eye clinician, may slow progression7. It has not been shown to prevent AMD in people without it3.

Months 3 to 12

Dry AMD usually worsens gradually over several years; wet AMD can worsen in days or weeks9. Check each eye in turn and report changes promptly10.

Long Term

Eye injections can slow late dry AMD but do not restore vision16; low-vision services and rehabilitation help people stay independent, and late AMD in one eye raises the risk in the other7.

When to Seek Care

Get eye care the same day for straight lines that suddenly look wavy or bent, a new dark, gray or empty patch in central vision, or rapid loss of central vision. Wet AMD is treatable, and time matters2. A dark curtain moving across your vision, or a red, painful eye, also needs eye care the same day9.

📬

Get new guides in your inbox. Once a month: new condition guides and research updates, including the trials that did not work. Free, no spam, and you can unsubscribe in one click.

Sign up

Next Steps

Your Stage Decides What Helps

What happens next depends on the type and stage of AMD. Wet AMD is treatable, and time matters, so get eye care the same day for straight lines that suddenly look wavy or a new dark patch in central vision. Stopping smoking starts now.

Explore High Blood Pressure → Explore Lung Cancer →

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed October 20, 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.17 This page is nutrition education, not medical advice, and it does not replace your doctor. Nutrition does not reverse macular degeneration, and no supplement restores vision that has been lost. The supplement evidence here is about slowing progression in people who already have a specific stage of the disease, and it does not apply to people who do not. Wet AMD is treated with injections and that treatment is time-critical, so nothing on this page is a reason to delay being seen. What nutrition education can do is help you understand the evidence well enough to have a better conversation with the clinician who does treat you.

  1. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2023;(9):CD000254. PubMed 37702300. Moderate-certainty evidence that the AREDS combination probably slows progression to late AMD, with people who have intermediate AMD more likely to benefit because their risk of progression is higher. Lutein and zeaxanthin alone against placebo showed little effect on low-certainty evidence, while subgroup analysis supported them as a replacement within the formula. ↩
  2. On how fast wet AMD should be seen: NICE recommends an urgent referral for suspected wet AMD, normally within 1 working day, and treatment as soon as possible, within 14 days of referral; NHS guidance advises an urgent optometrist appointment, or the NHS urgent advice line, when vision gets suddenly worse, NICE NG82, NHS, AMD symptoms. ↩
  3. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev. 2017;(7):CD000253. PubMed 28756617. The companion review by the same team, reaching the opposite conclusion for a different population: vitamin E or beta-carotene supplements will not prevent or delay the onset of AMD, and the same probably applies to vitamin C and to the multivitamin tested. ↩
  4. Chakravarthy U, Wong TY, Fletcher A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010;10:31. PubMed 21144031. Current smoking was among the strongest and most consistent modifiable associations with AMD. Age and genetic factors carry more weight overall and cannot be changed, which is why smoking is described here as the largest modifiable risk rather than the largest risk. ↩
  5. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-⁠1436. PubMed 11594942. The trial that established the formula. Its own conclusion limited the recommendation to people with extensive intermediate drusen, at least one large druse, non-central geographic atrophy, or advanced AMD or vision loss from AMD in one eye, and to those without contraindications such as smoking. ↩
  6. Chew EY, Clemons TE, Agrón E, et al. Long-term outcomes of adding lutein/​zeaxanthin and omega-⁠3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 report 28. JAMA Ophthalmol. 2022;140(7):692-⁠698. PubMed 35653117. Ten-year follow-up. The authors state that beta-carotene use nearly doubled the risk of lung cancer, with no statistically significant increase for lutein and zeaxanthin, and that omega-⁠3 fatty acids showed no effect on progression to late AMD. ↩
  7. On who has AMD and what treatment offers: the National Eye Institute states that 11 million people in the US have AMD, a leading cause of vision loss in older adults; that risk rises with age from 55 and is higher with a family history, in white people and in smokers; that it is found by a dilated eye examination, often with an OCT scan; that the special supplements may stop intermediate AMD from turning into late AMD, or slow AMD in the other eye when one eye has late AMD; that no treatment restores vision in late dry AMD, though vision rehabilitation helps people stay independent; and that late AMD in one eye raises the risk in the other, National Eye Institute, AMD. ↩
  8. Merle BMJ, Colijn JM, Cougnard-Grégoire A, et al. Mediterranean diet and incidence of advanced age-related macular degeneration: the EYE-RISK consortium. Ophthalmology. 2019;126(3):381-⁠390. PubMed 30114418. Higher adherence to a Mediterranean pattern was associated with lower incidence of advanced AMD across pooled European cohorts. Observational, so it establishes association rather than causation, and it is presented on this page as a sensible pattern rather than as a proven treatment. ↩
  9. On causes and pace: NHS guidance states that the exact cause of AMD is unknown but that it has been linked to aging, smoking, high blood pressure, being overweight and a family history; that dry AMD usually worsens gradually over several years while wet AMD can worsen in days or weeks; and that sudden worsening of vision, a dark curtain or shadow moving across vision, or a red and painful eye need an urgent appointment, NHS, AMD, NHS, AMD symptoms. ↩
  10. On risk factors and monitoring: the NICE guideline on AMD lists these risk factors: older age; AMD in the other eye; family history; smoking; high blood pressure; a BMI of 30 or more; a diet low in omega-⁠3 and omega-⁠6 fats, vitamins, carotenoids and minerals; a diet high in fat; and lack of exercise. It recommends ongoing OCT monitoring of both eyes in wet AMD and advises people with AMD to report a new blurred or gray patch, distorted straight lines or objects looking smaller to their eye-care professional as soon as possible, NICE NG82. ↩
  11. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-⁠3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005-⁠2015. PubMed 23644932. Adding omega-⁠3 fatty acids to the formula did not further reduce progression to advanced AMD. Lutein and zeaxanthin were tested as a replacement for beta-carotene. This is the reference for the honest statement that fish oil capsules are not an AMD treatment. ↩
  12. Goodman GE, Thornquist MD, Balmes J, et al. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial. Eur J Cancer Prev. 2007;16(3):175-⁠180. PubMed 17415088. High-dose beta-carotene supplementation increased lung cancer incidence in smokers and in asbestos-exposed workers. See the lung cancer guide. ↩
  13. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330(15):1029-⁠1035. PubMed 8127329. The earlier of the two trials, in male smokers. Cited with CARET because the finding was independently reproduced, which is why it is treated on this site as settled rather than as one surprising result. ↩
  14. On diet and AMD: a 2024 narrative review concludes that fruit, vegetables, fish and seafood, whole grains, olive oil, nuts and low-glycemic-index foods have been highlighted as beneficial for reducing AMD risk, and that the Mediterranean diet, which combines them, can be recommended as a pattern; the evidence it draws on is largely observational, PubMed 38221852. ↩
  15. Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine omega-⁠3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981-⁠1990. PubMed 34612056. Seven trials with 81,210 people followed for about 5 years: omega-⁠3 supplements were linked to a higher risk of atrial fibrillation (hazard ratio 1.25), more so in trials of more than 1 g a day (1.49), and the risk rose with each additional gram. ↩
  16. On treatment for late dry AMD: the American Academy of Ophthalmology states that two drugs injected into the eye, pegcetacoplan and avacincaptad pegol, have been approved by the FDA for geographic atrophy (the late form of dry AMD) and have been shown to slow its development by up to 20%, but that they do not improve vision or prevent vision loss, American Academy of Ophthalmology, new treatments for AMD. ↩
  17. National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu. ↩